CG
CLSD

Carmignac Gestion’s Clearside Biomedical CLSD Stock Holding History

Carmignac Gestion’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Hold
0
– -$1.73M – 118
2021
Q4 		– Hold
0
– – – 105
2021
Q3 		– Hold
0
– – – 117

Other funds holding CLSD

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Carmignac Gestion's CLSD Position: Q4 2025 in Review

Carmignac Gestion sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 100,556 shares — an estimated $399K sold.

Carmignac Gestion first reported a position in CLSD in Q1 2020 and held it in 23 quarters. The position peaked at $16.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.

  • Carmignac Gestion reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
  • Carmignac Gestion sold 100,556 Clearside Biomedical shares in Q4 2025, an estimated $399K.
  • Carmignac Gestion first reported a position in Clearside Biomedical in Q1 2020 and held it in 23 quarters.
  • Carmignac Gestion's Clearside Biomedical position peaked at $16.7M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.

Based on Carmignac Gestion's 13F filing for Q4 2025, filed 13 Feb 2026.